Identifying pathogenic proteins leads to potential new treatments for diseases such as diabetes.

Published Date: 02 Mar 2023

New research has identified hundreds of proteins that can lead to the development of metabolic diseases, such as type 2 diabetes mellitus, and therefore have treatment potential.

Read Full News

Latest News

Many Parents on Obesity Meds Discuss Treatment With Kids

Parents often discuss using obesity medications and related weight or behavior changes with their children.

Menopause Symptoms Worse in Women With Abdominal Obesity

Women with abdominal obesity report a higher burden of certain menopausal symptoms and exhibit a distinct pattern of symptom interrelationships relative to women without abdominal obesity.

Can Lower-Dose Tirzepatide Keep Weight Off?

New trial data suggest some patients may maintain meaningful weight loss after stepping down from the maximum dose of tirzepatide.

Pesticides May Help Explain Rising Early-Onset CRC Rates

A study linked a common herbicide to rising early-onset colorectal cancer, using DNA methylation to trace lifelong exposures rather than relying on patient recall.

Restarting GLP-1s After Stopping: How to Counsel Patients

Many patients taking GLP-1 RAs for weight loss discontinue within the first year. How can clinicians support long-term success with these drugs?

Exclusive-FDA Drug Center Head Expected to Leave After Commissioner's Exit, Sources Say

The acting head of the U.S. Food and Drug Administration's drug center, Tracey Beth Hoeg, is expected to leave the agency just days after Commissioner Marty ⁠Makary...

Todays Updates

Antibiotic Stewardship: Five Tips to Reduce Resistance

Clinicians continue prescribing antibiotics unnecessarily despite growing evidence supporting shorter, targeted, and reassessed treatment strategies.

France Expands 2026 Vaccination Rules Amid Resurgence

Nearly 300 experts warn that rising vaccine misinformation is reversing gains — measles and meningococcal infections are resurging while France updates the 2026 schedule.

Can Concurrent Boost Safely Shorten Breast Cancer Radiation?

Patients were randomly assigned 1:1 to receive either concurrent radiation dose escalation to the lumpectomy cavity during whole-breast irradiation or sequential boost after whole-breast irradiation.

FDA Expands Use of T-DXd in Early HER2+ Breast Cancer

The agency OK’d trastuzumab deruxtecan for two indications in HER2-positive early-stage breast cancer, covering both the neoadjuvant and adjuvant settings.

Todays Updates

Antibiotic Stewardship: Five Tips to Reduce Resistance

Clinicians continue prescribing antibiotics unnecessarily despite growing evidence supporting shorter, targeted, and reassessed treatment strategies.

France Expands 2026 Vaccination Rules Amid Resurgence

Nearly 300 experts warn that rising vaccine misinformation is reversing gains — measles and meningococcal infections are resurging while France updates the 2026 schedule.

Can Concurrent Boost Safely Shorten Breast Cancer Radiation?

Patients were randomly assigned 1:1 to receive either concurrent radiation dose escalation to the lumpectomy cavity during whole-breast irradiation or sequential boost after whole-breast irradiation.

FDA Expands Use of T-DXd in Early HER2+ Breast Cancer

The agency OK’d trastuzumab deruxtecan for two indications in HER2-positive early-stage breast cancer, covering both the neoadjuvant and adjuvant settings.

Latest News

Parents often discuss using obesity medications and related weight or behavior changes with their children.

Women with abdominal obesity report a higher burden of certain menopausal symptoms and exhibit a distinct pattern of symptom interrelationships relative to women without abdominal obesity.

New trial data suggest some patients may maintain meaningful weight loss after stepping down from the maximum dose of tirzepatide.

A study linked a common herbicide to rising early-onset colorectal cancer, using DNA methylation to trace lifelong exposures rather than relying on patient recall.

Many patients taking GLP-1 RAs for weight loss discontinue within the first year. How can clinicians support long-term success with these drugs?

The acting head of the U.S. Food and Drug Administration's drug center, Tracey Beth Hoeg, is expected to leave the agency just days after Commissioner Marty ⁠Makary...

News All Time

How Bariatric Surgery Shapes IBD Risk Over Time in Obesity

In patients with severe obesity, metabolic and bariatric surgery was linked to a lower risk for inflammatory bowel disease within 3 years but a higher risk over longer follow-up.

Acid Blockers May Worsen Gastro Effects of Weight-Loss Drugs

The dual-medication group shows a significantly higher risk for several conditions.

Longer Abstinence May Reduce Sperm Quality Over Time

Prolonged sperm storage may reduce motility and vitality through oxidative stress and DNA damage, thereby affecting fertility.

Why Patients Stop Treatment and How Clinicians Can Help

Medication adherence often declines over time, but targeted communication and simpler regimens may help improve long-term treatment outcomes.

Want to Know What Caused Cushing? Urine Tests Can Help

Urinary free cortisol expressed as times above the upper limit of normal is a strong discriminator between ectopic ACTH-dependent and pituitary Cushing syndrome, according to a Spanish study.

Hidden Sugar Traps Patients With Diabetes Should Recognize

Food labels are often misleading when it comes to glycemic impacts.

Previous Pregnancy Signals Lower Folic Acid Use

Women with previous pregnancies are consistently less likely than first-time mothers to take folic acid supplements before conception and during early pregnancy, a meta-analysis shows.

Oral Orforglipron Effective in Older Adults With Obesity

People over 65 taking once-daily oral orforglipron achieved substantial weight loss with a consistent safety profile, regardless of T2D status, in a post hoc ATTAIN trial analysis.

Refining Management Strategies for Patients With Endometriosis

Refining Management Strategies for Patients With Endometriosis

Toddler Has Menstrual Cycle at 17 Months

Clinicians ruled out precocious puberty before landing on a diagnosis of exclusion

Accurate and Timely Diagnosis of Endometriosis

Accurate and Timely Diagnosis of Endometriosis

Recognizing the Multifactorial Barriers to Effective Weight Loss in Obesity

Recognizing the Multifactorial Barriers to Effective Weight Loss in Obesity

Bridging Specialties to Manage Hyperglycemia in Breast Cancer Patients Treated With PI3K/AKT Pathway Inhibitors

Bridging Specialties to Manage Hyperglycemia in Breast Cancer Patients Treated With PI3K/AKT Pathway Inhibitors

From Crisis to Control: Strategies to Address Recurrent Severe Hypoglycemia in Type 1 Diabetes

From Crisis to Control: Strategies to Address Recurrent Severe Hypoglycemia in Type 1 Diabetes

Contraceptive Considerations in the Modern Era: Navigating Non-Oral Options and Evolving Clinical Complexities

Contraceptive Considerations in the Modern Era: Navigating Non-Oral Options and Evolving Clinical Complexities

Doctors Urge Women to Be Wary of Marketing Surge in Menopause Products

"It really pays to be very, very, very skeptical," says one expert

Recommended News For You

In cases of locally advanced, potentially curable pancreatic cancer, a combination of drugs enhances the results of radiation therapy.

For MDS-Related Anemia, Telomerase Inhibitor Approved.

Both men and women who receive the HPV vaccine have a lower risk of developing multiple cancer types.

I Was Told I Had 6 Months to Live. That Was 20 Years Ago.

Chemoimmunotherapy Boosts Head and Neck Cancer Response

Imetelstat for MDS-relateret anemia er godkendt af Food and Drug Administrations panel.

Pirtobrutinib May Be Beneficial in Follicular Lymphoma with Severe Pretreatment.

Recommended Articles For You

Angina Haemorrhagica Bullosa: What You Need to Know 

Liquid Biopsies in Hematology: A Window into the Disease 

The Journey Beyond Treatment: Empowering Cancer Survivorship with Technology and Artificial Intelligence 

Bridging Heart and Cancer Care: The Essential Framework of a Modern Cardio-Oncology Program 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

GLP-1 drugs linked to dramatically lower death rates in colon cancer patients

2.

Preoperative MRI is useful for identifying additional disease in breast cancer patients with nodes positive.

3.

PFS in Multiple Myeloma Is Improved by Daratumumab Added to Standard Therapy.

4.

TULSA Is Effective in Long-Term Prostate Cancer Control.

5.

Rising rates of head and neck cancers in England

1.

Case Study: Advancing Preclinical Oncology Drug Development with Quantitative Systems Pharmacology

2.

Anion Gap: The Simple Calculation That Reveals Much About Your Health 

3.

Understanding Mantle Cell Lymphoma Prognosis.

4.

Bridging Heart and Cancer Care: The Essential Framework of a Modern Cardio-Oncology Program

5.

Liquid Biopsy: Revolutionizing Precision Oncology in Hematological Malignancies

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Efficient Management of First line ALK-rearranged NSCLC

2.

The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management- Further Discussion

3.

Efficient Management of First line ALK-rearranged NSCLC - Part III

4.

Dacomitinib Case Presentation: Baseline Treatment and Current Status

5.

An In-Depth Look At The Signs And Symptoms Of Lymphoma

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot